Cargando…
Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer
Purpose: Standard chemoradiation therapy for stage III non-small cell lung cancer (NSCLCa) results in suboptimal outcomes with a high rate of local failure and poor overall survival. We hypothesize that dose escalation using stereotactic body radiotherapy (SBRT) boost could improve upon these result...
Autores principales: | Hepel, Jaroslaw T., Peter, Justin, Hiatt, Jessica R., Patel, Salil, Osibanjo, Oluwademilade, Safran, Howard, Curran, Bruce, DiPetrillo, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458262/ https://www.ncbi.nlm.nih.gov/pubmed/23057009 http://dx.doi.org/10.3389/fonc.2012.00124 |
Ejemplares similares
-
Axillary lymph node dose with tangential whole breast radiation in the prone versus supine position: a dosimetric study
por: Leonard, Kara Lynne, et al.
Publicado: (2012) -
Feasibility and safety of cavity-directed stereotactic radiosurgery for brain metastases at a high-volume medical center
por: Rava, Paul, et al.
Publicado: (2016) -
Dosimetric Impact of Intrafraction Prostate Motion and Interfraction Anatomical Changes in Dose-Escalated Linac-Based SBRT
por: Faccenda, Valeria, et al.
Publicado: (2023) -
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar
por: Mazzarotto, Renzo, et al.
Publicado: (2020) -
Dosimetric Analysis of Microscopic Disease in SBRT for Lung Cancers
por: Mao, Ronghu, et al.
Publicado: (2017)